Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 46.67 USD 1.08% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Enovis Corp?
Write Note

Enovis Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enovis Corp
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Enovis Corp
NYSE:ENOV
Cost of Revenue
-$713.8m
CAGR 3-Years
26%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.9B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.3B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.6B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
No Stocks Found

Enovis Corp
Glance View

Market Cap
2.6B USD
Industry
Health Care

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

ENOV Intrinsic Value
72.78 USD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Enovis Corp's Cost of Revenue?
Cost of Revenue
-713.8m USD

Based on the financial report for Dec 31, 2023, Enovis Corp's Cost of Revenue amounts to -713.8m USD.

What is Enovis Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
13%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Enovis Corp have been 26% over the past three years , 13% over the past five years .

Back to Top